Service & Software
Global Hospital-Acquired Infection Control Market Research Report 2024
- Jan 18, 24
- ID: 2477
- Pages: 76
- Figures: 144
- Views: 19
HAI is a term used to describe all infections that do not stem from the patient’s original diagnosis on admission.
HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.
The global Hospital-Acquired Infection Control market was valued at US$ 5702.2 million in 2023 and is anticipated to reach US$ 6985.5 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Infection Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Infection Control.
Report Scope
The Hospital-Acquired Infection Control market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-Acquired Infection Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-Acquired Infection Control companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group
Segment by Type
Catheter-associated Urinary Tract Infections (CAUTIs)
Surgical Site Infections (SSIs)
Central Line-associated Bloodstream Infections (CLABSIs)
Respiratory Infections
Segment by Application
Hospitals and ICUs
Outpatient Care Centers
Long-term Care Facilities (LTCFs)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-Acquired Infection Control companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HAIs are caused by bacteria, viruses or parasites that originate from the hospital environment, contaminated equipment, staff, or other patients. The most common types are urinary tract infections, chest infections, and surgical wound infections.
The global Hospital-Acquired Infection Control market was valued at US$ 5702.2 million in 2023 and is anticipated to reach US$ 6985.5 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital-Acquired Infection Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-Acquired Infection Control.
Report Scope
The Hospital-Acquired Infection Control market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-Acquired Infection Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-Acquired Infection Control companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Merck
Pfizer
3M
Abbott
BD
Cepheid
Getinge Group
Segment by Type
Catheter-associated Urinary Tract Infections (CAUTIs)
Surgical Site Infections (SSIs)
Central Line-associated Bloodstream Infections (CLABSIs)
Respiratory Infections
Segment by Application
Hospitals and ICUs
Outpatient Care Centers
Long-term Care Facilities (LTCFs)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-Acquired Infection Control companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Infection Control Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Catheter-associated Urinary Tract Infections (CAUTIs)
1.2.3 Surgical Site Infections (SSIs)
1.2.4 Central Line-associated Bloodstream Infections (CLABSIs)
1.2.5 Respiratory Infections
1.3 Market by Application
1.3.1 Global Hospital-Acquired Infection Control Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and ICUs
1.3.3 Outpatient Care Centers
1.3.4 Long-term Care Facilities (LTCFs)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Acquired Infection Control Market Perspective (2019-2030)
2.2 Hospital-Acquired Infection Control Growth Trends by Region
2.2.1 Global Hospital-Acquired Infection Control Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital-Acquired Infection Control Historic Market Size by Region (2019-2024)
2.2.3 Hospital-Acquired Infection Control Forecasted Market Size by Region (2025-2030)
2.3 Hospital-Acquired Infection Control Market Dynamics
2.3.1 Hospital-Acquired Infection Control Industry Trends
2.3.2 Hospital-Acquired Infection Control Market Drivers
2.3.3 Hospital-Acquired Infection Control Market Challenges
2.3.4 Hospital-Acquired Infection Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Infection Control Players by Revenue
3.1.1 Global Top Hospital-Acquired Infection Control Players by Revenue (2019-2024)
3.1.2 Global Hospital-Acquired Infection Control Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Infection Control Revenue
3.4 Global Hospital-Acquired Infection Control Market Concentration Ratio
3.4.1 Global Hospital-Acquired Infection Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Infection Control Revenue in 2023
3.5 Hospital-Acquired Infection Control Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Infection Control Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Infection Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-Acquired Infection Control Breakdown Data by Type
4.1 Global Hospital-Acquired Infection Control Historic Market Size by Type (2019-2024)
4.2 Global Hospital-Acquired Infection Control Forecasted Market Size by Type (2025-2030)
5 Hospital-Acquired Infection Control Breakdown Data by Application
5.1 Global Hospital-Acquired Infection Control Historic Market Size by Application (2019-2024)
5.2 Global Hospital-Acquired Infection Control Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital-Acquired Infection Control Market Size (2019-2030)
6.2 North America Hospital-Acquired Infection Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital-Acquired Infection Control Market Size by Country (2019-2024)
6.4 North America Hospital-Acquired Infection Control Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-Acquired Infection Control Market Size (2019-2030)
7.2 Europe Hospital-Acquired Infection Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital-Acquired Infection Control Market Size by Country (2019-2024)
7.4 Europe Hospital-Acquired Infection Control Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Infection Control Market Size (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Infection Control Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital-Acquired Infection Control Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital-Acquired Infection Control Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-Acquired Infection Control Market Size (2019-2030)
9.2 Latin America Hospital-Acquired Infection Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital-Acquired Infection Control Market Size by Country (2019-2024)
9.4 Latin America Hospital-Acquired Infection Control Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Infection Control Market Size (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Infection Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital-Acquired Infection Control Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital-Acquired Infection Control Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Hospital-Acquired Infection Control Introduction
11.1.4 GSK Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Hospital-Acquired Infection Control Introduction
11.2.4 Merck Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Hospital-Acquired Infection Control Introduction
11.3.4 Pfizer Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 3M
11.4.1 3M Company Detail
11.4.2 3M Business Overview
11.4.3 3M Hospital-Acquired Infection Control Introduction
11.4.4 3M Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.4.5 3M Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Hospital-Acquired Infection Control Introduction
11.5.4 Abbott Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Hospital-Acquired Infection Control Introduction
11.6.4 BD Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.6.5 BD Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Detail
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Hospital-Acquired Infection Control Introduction
11.7.4 Cepheid Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.7.5 Cepheid Recent Development
11.8 Getinge Group
11.8.1 Getinge Group Company Detail
11.8.2 Getinge Group Business Overview
11.8.3 Getinge Group Hospital-Acquired Infection Control Introduction
11.8.4 Getinge Group Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.8.5 Getinge Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-Acquired Infection Control Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Catheter-associated Urinary Tract Infections (CAUTIs)
1.2.3 Surgical Site Infections (SSIs)
1.2.4 Central Line-associated Bloodstream Infections (CLABSIs)
1.2.5 Respiratory Infections
1.3 Market by Application
1.3.1 Global Hospital-Acquired Infection Control Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and ICUs
1.3.3 Outpatient Care Centers
1.3.4 Long-term Care Facilities (LTCFs)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-Acquired Infection Control Market Perspective (2019-2030)
2.2 Hospital-Acquired Infection Control Growth Trends by Region
2.2.1 Global Hospital-Acquired Infection Control Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital-Acquired Infection Control Historic Market Size by Region (2019-2024)
2.2.3 Hospital-Acquired Infection Control Forecasted Market Size by Region (2025-2030)
2.3 Hospital-Acquired Infection Control Market Dynamics
2.3.1 Hospital-Acquired Infection Control Industry Trends
2.3.2 Hospital-Acquired Infection Control Market Drivers
2.3.3 Hospital-Acquired Infection Control Market Challenges
2.3.4 Hospital-Acquired Infection Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-Acquired Infection Control Players by Revenue
3.1.1 Global Top Hospital-Acquired Infection Control Players by Revenue (2019-2024)
3.1.2 Global Hospital-Acquired Infection Control Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-Acquired Infection Control Revenue
3.4 Global Hospital-Acquired Infection Control Market Concentration Ratio
3.4.1 Global Hospital-Acquired Infection Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Infection Control Revenue in 2023
3.5 Hospital-Acquired Infection Control Key Players Head office and Area Served
3.6 Key Players Hospital-Acquired Infection Control Product Solution and Service
3.7 Date of Enter into Hospital-Acquired Infection Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-Acquired Infection Control Breakdown Data by Type
4.1 Global Hospital-Acquired Infection Control Historic Market Size by Type (2019-2024)
4.2 Global Hospital-Acquired Infection Control Forecasted Market Size by Type (2025-2030)
5 Hospital-Acquired Infection Control Breakdown Data by Application
5.1 Global Hospital-Acquired Infection Control Historic Market Size by Application (2019-2024)
5.2 Global Hospital-Acquired Infection Control Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital-Acquired Infection Control Market Size (2019-2030)
6.2 North America Hospital-Acquired Infection Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital-Acquired Infection Control Market Size by Country (2019-2024)
6.4 North America Hospital-Acquired Infection Control Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-Acquired Infection Control Market Size (2019-2030)
7.2 Europe Hospital-Acquired Infection Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital-Acquired Infection Control Market Size by Country (2019-2024)
7.4 Europe Hospital-Acquired Infection Control Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-Acquired Infection Control Market Size (2019-2030)
8.2 Asia-Pacific Hospital-Acquired Infection Control Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital-Acquired Infection Control Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital-Acquired Infection Control Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-Acquired Infection Control Market Size (2019-2030)
9.2 Latin America Hospital-Acquired Infection Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital-Acquired Infection Control Market Size by Country (2019-2024)
9.4 Latin America Hospital-Acquired Infection Control Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-Acquired Infection Control Market Size (2019-2030)
10.2 Middle East & Africa Hospital-Acquired Infection Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital-Acquired Infection Control Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital-Acquired Infection Control Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Hospital-Acquired Infection Control Introduction
11.1.4 GSK Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.1.5 GSK Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Hospital-Acquired Infection Control Introduction
11.2.4 Merck Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Hospital-Acquired Infection Control Introduction
11.3.4 Pfizer Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 3M
11.4.1 3M Company Detail
11.4.2 3M Business Overview
11.4.3 3M Hospital-Acquired Infection Control Introduction
11.4.4 3M Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.4.5 3M Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Hospital-Acquired Infection Control Introduction
11.5.4 Abbott Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.5.5 Abbott Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Hospital-Acquired Infection Control Introduction
11.6.4 BD Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.6.5 BD Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Detail
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Hospital-Acquired Infection Control Introduction
11.7.4 Cepheid Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.7.5 Cepheid Recent Development
11.8 Getinge Group
11.8.1 Getinge Group Company Detail
11.8.2 Getinge Group Business Overview
11.8.3 Getinge Group Hospital-Acquired Infection Control Introduction
11.8.4 Getinge Group Revenue in Hospital-Acquired Infection Control Business (2019-2024)
11.8.5 Getinge Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hospital-Acquired Infection Control Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Catheter-associated Urinary Tract Infections (CAUTIs)
Table 3. Key Players of Surgical Site Infections (SSIs)
Table 4. Key Players of Central Line-associated Bloodstream Infections (CLABSIs)
Table 5. Key Players of Respiratory Infections
Table 6. Global Hospital-Acquired Infection Control Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Hospital-Acquired Infection Control Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Hospital-Acquired Infection Control Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Hospital-Acquired Infection Control Market Share by Region (2019-2024)
Table 10. Global Hospital-Acquired Infection Control Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Hospital-Acquired Infection Control Market Share by Region (2025-2030)
Table 12. Hospital-Acquired Infection Control Market Trends
Table 13. Hospital-Acquired Infection Control Market Drivers
Table 14. Hospital-Acquired Infection Control Market Challenges
Table 15. Hospital-Acquired Infection Control Market Restraints
Table 16. Global Hospital-Acquired Infection Control Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Hospital-Acquired Infection Control Market Share by Players (2019-2024)
Table 18. Global Top Hospital-Acquired Infection Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection Control as of 2023)
Table 19. Ranking of Global Top Hospital-Acquired Infection Control Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Hospital-Acquired Infection Control Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hospital-Acquired Infection Control Product Solution and Service
Table 23. Date of Enter into Hospital-Acquired Infection Control Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hospital-Acquired Infection Control Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Hospital-Acquired Infection Control Revenue Market Share by Type (2019-2024)
Table 27. Global Hospital-Acquired Infection Control Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Hospital-Acquired Infection Control Revenue Market Share by Type (2025-2030)
Table 29. Global Hospital-Acquired Infection Control Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Hospital-Acquired Infection Control Revenue Market Share by Application (2019-2024)
Table 31. Global Hospital-Acquired Infection Control Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Hospital-Acquired Infection Control Revenue Market Share by Application (2025-2030)
Table 33. North America Hospital-Acquired Infection Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Hospital-Acquired Infection Control Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Hospital-Acquired Infection Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Hospital-Acquired Infection Control Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Hospital-Acquired Infection Control Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Hospital-Acquired Infection Control Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Hospital-Acquired Infection Control Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Hospital-Acquired Infection Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hospital-Acquired Infection Control Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hospital-Acquired Infection Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Hospital-Acquired Infection Control Market Size by Country (2025-2030) & (US$ Million)
Table 48. GSK Company Detail
Table 49. GSK Business Overview
Table 50. GSK Hospital-Acquired Infection Control Product
Table 51. GSK Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 52. GSK Recent Development
Table 53. Merck Company Detail
Table 54. Merck Business Overview
Table 55. Merck Hospital-Acquired Infection Control Product
Table 56. Merck Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Hospital-Acquired Infection Control Product
Table 61. Pfizer Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. 3M Company Detail
Table 64. 3M Business Overview
Table 65. 3M Hospital-Acquired Infection Control Product
Table 66. 3M Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 67. 3M Recent Development
Table 68. Abbott Company Detail
Table 69. Abbott Business Overview
Table 70. Abbott Hospital-Acquired Infection Control Product
Table 71. Abbott Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 72. Abbott Recent Development
Table 73. BD Company Detail
Table 74. BD Business Overview
Table 75. BD Hospital-Acquired Infection Control Product
Table 76. BD Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 77. BD Recent Development
Table 78. Cepheid Company Detail
Table 79. Cepheid Business Overview
Table 80. Cepheid Hospital-Acquired Infection Control Product
Table 81. Cepheid Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 82. Cepheid Recent Development
Table 83. Getinge Group Company Detail
Table 84. Getinge Group Business Overview
Table 85. Getinge Group Hospital-Acquired Infection Control Product
Table 86. Getinge Group Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 87. Getinge Group Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Acquired Infection Control Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hospital-Acquired Infection Control Market Share by Type: 2023 VS 2030
Figure 3. Catheter-associated Urinary Tract Infections (CAUTIs) Features
Figure 4. Surgical Site Infections (SSIs) Features
Figure 5. Central Line-associated Bloodstream Infections (CLABSIs) Features
Figure 6. Respiratory Infections Features
Figure 7. Global Hospital-Acquired Infection Control Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Hospital-Acquired Infection Control Market Share by Application: 2023 VS 2030
Figure 9. Hospitals and ICUs Case Studies
Figure 10. Outpatient Care Centers Case Studies
Figure 11. Long-term Care Facilities (LTCFs) Case Studies
Figure 12. Hospital-Acquired Infection Control Report Years Considered
Figure 13. Global Hospital-Acquired Infection Control Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Hospital-Acquired Infection Control Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Hospital-Acquired Infection Control Market Share by Region: 2023 VS 2030
Figure 16. Global Hospital-Acquired Infection Control Market Share by Players in 2023
Figure 17. Global Top Hospital-Acquired Infection Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection Control as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Hospital-Acquired Infection Control Revenue in 2023
Figure 19. North America Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Hospital-Acquired Infection Control Market Share by Country (2019-2030)
Figure 21. United States Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Hospital-Acquired Infection Control Market Share by Country (2019-2030)
Figure 25. Germany Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Hospital-Acquired Infection Control Market Share by Region (2019-2030)
Figure 33. China Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Hospital-Acquired Infection Control Market Share by Country (2019-2030)
Figure 41. Mexico Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Hospital-Acquired Infection Control Market Share by Country (2019-2030)
Figure 45. Turkey Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 48. Merck Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 50. 3M Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 51. Abbott Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 52. BD Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 53. Cepheid Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 54. Getinge Group Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Hospital-Acquired Infection Control Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Catheter-associated Urinary Tract Infections (CAUTIs)
Table 3. Key Players of Surgical Site Infections (SSIs)
Table 4. Key Players of Central Line-associated Bloodstream Infections (CLABSIs)
Table 5. Key Players of Respiratory Infections
Table 6. Global Hospital-Acquired Infection Control Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Hospital-Acquired Infection Control Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Hospital-Acquired Infection Control Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Hospital-Acquired Infection Control Market Share by Region (2019-2024)
Table 10. Global Hospital-Acquired Infection Control Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Hospital-Acquired Infection Control Market Share by Region (2025-2030)
Table 12. Hospital-Acquired Infection Control Market Trends
Table 13. Hospital-Acquired Infection Control Market Drivers
Table 14. Hospital-Acquired Infection Control Market Challenges
Table 15. Hospital-Acquired Infection Control Market Restraints
Table 16. Global Hospital-Acquired Infection Control Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Hospital-Acquired Infection Control Market Share by Players (2019-2024)
Table 18. Global Top Hospital-Acquired Infection Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection Control as of 2023)
Table 19. Ranking of Global Top Hospital-Acquired Infection Control Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Hospital-Acquired Infection Control Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Hospital-Acquired Infection Control Product Solution and Service
Table 23. Date of Enter into Hospital-Acquired Infection Control Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Hospital-Acquired Infection Control Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Hospital-Acquired Infection Control Revenue Market Share by Type (2019-2024)
Table 27. Global Hospital-Acquired Infection Control Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Hospital-Acquired Infection Control Revenue Market Share by Type (2025-2030)
Table 29. Global Hospital-Acquired Infection Control Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Hospital-Acquired Infection Control Revenue Market Share by Application (2019-2024)
Table 31. Global Hospital-Acquired Infection Control Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Hospital-Acquired Infection Control Revenue Market Share by Application (2025-2030)
Table 33. North America Hospital-Acquired Infection Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Hospital-Acquired Infection Control Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Hospital-Acquired Infection Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Hospital-Acquired Infection Control Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Hospital-Acquired Infection Control Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Hospital-Acquired Infection Control Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Hospital-Acquired Infection Control Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Hospital-Acquired Infection Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hospital-Acquired Infection Control Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hospital-Acquired Infection Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Hospital-Acquired Infection Control Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Hospital-Acquired Infection Control Market Size by Country (2025-2030) & (US$ Million)
Table 48. GSK Company Detail
Table 49. GSK Business Overview
Table 50. GSK Hospital-Acquired Infection Control Product
Table 51. GSK Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 52. GSK Recent Development
Table 53. Merck Company Detail
Table 54. Merck Business Overview
Table 55. Merck Hospital-Acquired Infection Control Product
Table 56. Merck Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 57. Merck Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Hospital-Acquired Infection Control Product
Table 61. Pfizer Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. 3M Company Detail
Table 64. 3M Business Overview
Table 65. 3M Hospital-Acquired Infection Control Product
Table 66. 3M Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 67. 3M Recent Development
Table 68. Abbott Company Detail
Table 69. Abbott Business Overview
Table 70. Abbott Hospital-Acquired Infection Control Product
Table 71. Abbott Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 72. Abbott Recent Development
Table 73. BD Company Detail
Table 74. BD Business Overview
Table 75. BD Hospital-Acquired Infection Control Product
Table 76. BD Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 77. BD Recent Development
Table 78. Cepheid Company Detail
Table 79. Cepheid Business Overview
Table 80. Cepheid Hospital-Acquired Infection Control Product
Table 81. Cepheid Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 82. Cepheid Recent Development
Table 83. Getinge Group Company Detail
Table 84. Getinge Group Business Overview
Table 85. Getinge Group Hospital-Acquired Infection Control Product
Table 86. Getinge Group Revenue in Hospital-Acquired Infection Control Business (2019-2024) & (US$ Million)
Table 87. Getinge Group Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-Acquired Infection Control Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hospital-Acquired Infection Control Market Share by Type: 2023 VS 2030
Figure 3. Catheter-associated Urinary Tract Infections (CAUTIs) Features
Figure 4. Surgical Site Infections (SSIs) Features
Figure 5. Central Line-associated Bloodstream Infections (CLABSIs) Features
Figure 6. Respiratory Infections Features
Figure 7. Global Hospital-Acquired Infection Control Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Hospital-Acquired Infection Control Market Share by Application: 2023 VS 2030
Figure 9. Hospitals and ICUs Case Studies
Figure 10. Outpatient Care Centers Case Studies
Figure 11. Long-term Care Facilities (LTCFs) Case Studies
Figure 12. Hospital-Acquired Infection Control Report Years Considered
Figure 13. Global Hospital-Acquired Infection Control Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Hospital-Acquired Infection Control Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Hospital-Acquired Infection Control Market Share by Region: 2023 VS 2030
Figure 16. Global Hospital-Acquired Infection Control Market Share by Players in 2023
Figure 17. Global Top Hospital-Acquired Infection Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-Acquired Infection Control as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Hospital-Acquired Infection Control Revenue in 2023
Figure 19. North America Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Hospital-Acquired Infection Control Market Share by Country (2019-2030)
Figure 21. United States Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Hospital-Acquired Infection Control Market Share by Country (2019-2030)
Figure 25. Germany Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Hospital-Acquired Infection Control Market Share by Region (2019-2030)
Figure 33. China Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Hospital-Acquired Infection Control Market Share by Country (2019-2030)
Figure 41. Mexico Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Hospital-Acquired Infection Control Market Share by Country (2019-2030)
Figure 45. Turkey Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Hospital-Acquired Infection Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 48. Merck Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 50. 3M Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 51. Abbott Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 52. BD Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 53. Cepheid Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 54. Getinge Group Revenue Growth Rate in Hospital-Acquired Infection Control Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232